Safety and Pain Relief of Tanezumab in Patients with Osteoarthritis of the Hip or Knee
A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee
Category & Conditions: Neurological Diseases and Conditions
Medicine: tanezumab
ClinicalTrials.gov Identifier (NCT): NCT02528188
Protocol ID: A4091058
PrintDownloadOpen Plain Language Summary Result: Click here